Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma. (13th June 2018)

• Record Type: Journal Article
• Authors: Eskian, Mahsa; Khorasanizadeh, MirHojjat; Isidori, Alessandro; Rezaei, Nima
• Is Part Of: International journal of hematologic oncology. Volume 7:Number 1(2018)
• Publication Date: 2018-06-13
• Subjects: autologous stem cell transplantation -- conditioning -- non-Hodgkin lymphoma -- radioimmunotherapy -- toxicity; Hematological oncology -- Periodicals; 616.99418
• DOI: 10.2217/ijh-2017-0025
• Languages: English
• ISSNs: 2045-1393

Abstract

Non-Hodgkin lymphoma (NHL) is the most common hematologic malignancy and the sixth cause of death from cancer in the USA. Autologous stem cell transplantation (ASCT) is a potentially curative therapeutic option for many NHL patients. Choosing the most effective conditioning regimen prior to ASCT can lead to longer survival in these patients, and, as in many cases of high risk NHL, the only potentially curative option is stem cell transplantation. Radioimmunotherapy (RIT) is based on using radiolabeled monoclonal antibodies against tumoral antigens. Since lymphoma cells are sensitive to radiation, RIT has become a potential approach in treating NHL. In this review, we have discussed the efficacy and safety of RIT as an alternative conditioning regimen prior to ASCT.